سوق معدات إذابة العلاج بالخلايا والجينات في أوروبا، حسب النمط (على طاولة العمل والمحمولة)، العينة (العلاجات الخلوية والعلاجات الجينية)، النوع ( نظام إذابة يدوي ونظام إذابة أوتوماتيكي)، التطبيق (المعالجة الأولية والمعالجة النهائية)، المستخدم النهائي ( بنوك الدم ومراكز نقل الدم، المستشفيات ومختبرات التشخيص، مختبرات الأبحاث والمعاهد الأكاديمية، صناعة التكنولوجيا الحيوية والأدوية ، بنوك دم الحبل السري والخلايا الجذعية، بنوك الجينات وغيرها)، قناة التوزيع (العطاء المباشر، الموزع التابع لجهة خارجية وغيرها)، الدولة (المملكة المتحدة وألمانيا وفرنسا وإسبانيا وإيطاليا وهولندا وسويسرا وروسيا وبلجيكا وتركيا وأيرلندا وبقية أوروبا) اتجاهات الصناعة والتوقعات حتى عام 2028.
تحليل السوق والرؤى: سوق معدات إذابة الخلايا والعلاج الجيني في أوروبا
من المتوقع أن يكتسب سوق معدات إذابة العلاج بالخلايا والجينات نموًا في السوق في الفترة المتوقعة من 2021 إلى 2028. تحلل Data Bridge Market Research أن السوق ينمو بمعدل نمو سنوي مركب بنسبة 13.3٪ في الفترة المتوقعة من 2021 إلى 2028 ومن المتوقع أن يصل إلى 444.15 مليون دولار أمريكي بحلول عام 2028. يتطلب الانتشار المتزايد للأمراض المزمنة حلول وخدمات معدات إذابة العلاج بالخلايا والجينات المتقدمة، وبالتالي يعمل كمحرك لنمو سوق معدات إذابة العلاج بالخلايا والجينات.
أصبحت معدات إذابة الخلايا والعلاج الجيني سهلة بسبب التقدم في التكنولوجيا حيث يقوم عدد من اللاعبين الرئيسيين في السوق بتطوير وإطلاق حلول جديدة لتوسيع سوقهم. علاوة على ذلك، أدى ارتفاع الإنفاق على الرعاية الصحية في البلدان المتقدمة والنامية إلى تغذية نمو سوق معدات إذابة الخلايا والعلاج الجيني. ينمو سوق معدات إذابة الخلايا والعلاج الجيني بسبب زيادة حالات الأمراض المزمنة وارتفاع التقدم التكنولوجي.
إن الانتشار المتزايد للأمراض المزمنة يعمل كمحرك لسوق معدات إذابة الخلايا والعلاج الجيني. إن ارتفاع التكلفة المرتبطة بهندسة العلاج الجيني والخلايا يقلل من الطلب على معدات إذابة الخلايا والعلاج الجيني مما يعيق نمو سوق معدات إذابة الخلايا والعلاج الجيني. إن الارتفاع في التقدم التكنولوجي الجديد يعمل كفرصة لسوق معدات إذابة الخلايا والعلاج الجيني. ومع ذلك، فإن عدم إمكانية الوصول في البلدان المنخفضة والمتوسطة الدخل يشكل تحديًا لنمو سوق معدات إذابة الخلايا والعلاج الجيني.
The cell and gene therapy thawing equipment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the cell and gene therapy thawing equipment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Cell and gene therapy thawing equipment Market Scope and Market Size
The cell and gene therapy thawing equipment market is segmented on the based on the modality, sample, type, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of Sample, the cell and gene therapy thawing equipment market is segmented into cell therapies and gene therapies. In 2021, the cell therapy segment is expected to dominate the cell and gene therapy thawing equipment market due to rising prevalence and incidence of cancer.
- On the basis of type, the cell and gene therapy thawing equipment market is segmented into manual thawing system and automatic thawing system. In 2021, the automatic thawing system segment is expected to dominate the cell and gene therapy thawing equipment market as it improves reproducibility and minimizes human error.
- On the basis of application, the cell and gene therapy thawing equipment market is segmented into upstream processing and downstream processing. In 2021, the upstream processing segment is expected to dominate the cell and gene therapy thawing equipment market due to rising technological advancements in the thawing systems.
- On the basis of end user, the cell and gene therapy thawing equipment market is segmented into blood banks and transfusion centers, hospitals and diagnostic laboratories, research laboratories and academic institutes, biotechnology and pharmaceutical industry, cord blood and stem cell banks, gene banks and others. In 2021, the blood banks segment is expected to dominate the Cell and gene therapy thawing equipment market due to rise in number of blood banks and advanced healthcare providers in low and middle income countries.
- On the basis of distribution channel, the cell and gene therapy thawing equipment market is segmented into direct tender, third part distributor and others. In 2021, the direct tender segment is expected to dominate the cell and gene therapy thawing equipment market as majority of healthcare provider’s procured cell and gene therapy thawing equipment right from direct tender.
Cell and Gene Therapy Thawing Equipment Market Country Level Analysis
The cell and gene therapy thawing equipment market is segmented on the based on the modality, sample, type, application, end user and distribution channel.
The countries covered in the cell and gene therapy thawing equipment market report are the Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Austria, Ireland, and Rest of Europe.
Germany is expected to dominate the European market due to rising technological advancements.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Cell and Gene Therapy Thawing Equipment, is Boosting the Market Growth of Cell and Gene Therapy Thawing Equipment Market
The cell and gene therapy thawing equipment market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Cell and gene therapy thawing equipment Market Share Analysis
Cell and gene therapy thawing equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to cell and gene therapy thawing equipment market.
The major companies which are dealing in the cell and gene therapy thawing equipment are Pluristem Therapeutics Inc., Genesis BPS, Eppendorf AG, Cytiva (A subsidiary of Danaher Corporation), Glenmark Pharmaceutical Inc., USA (A subsidiary of Glenmark), EDGE pharma, Cook, SARSTEDT AG & Co. KG, Barkey, Boekel Scientific, LABCOLD, Sartorious AG and Helmer Scientific Inc. among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the cell and gene therapy thawing equipment market.
For instance,
- في نوفمبر 2020، أطلقت شركة Eppendorg AG جهاز SmartBlock لإزالة الخلايا في الهند. يعد جهاز Smart Block لإزالة الخلايا أساسًا للمعالجة اللاحقة. وهو سهل ومريح للعلماء لاستخدامه في كل مختبر لمعالجة الخلايا.
إن التعاون وإطلاق المنتج وتوسيع الأعمال والجوائز والتقدير والمشاريع المشتركة والاستراتيجيات الأخرى من قبل اللاعب في السوق تعمل على تعزيز بصمة الشركة في سوق معدات إذابة العلاج بالخلايا والجينات مما يوفر أيضًا فائدة لنمو أرباح المنظمة.
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 USAGE OF THAWING EQUIPMENT IN UPSTREAM AND DOWNSTREAM PROCESSES
5.1 UPSTREAM PROCESS
5.2 DOWNSTREAM PROCESS
6 CELL AND GENE THERAPY WORKFLOW USING THAWING EQUIPMENT
7 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: REGULATIONS
7.1 CANADA
7.2 THE U.S.
7.3 EUROPE
7.4 GENE THERAPY LEGISLATION IN AUSTRIA
7.5 GENE THERAPY LEGISLATION IN BULGARIA
7.6 JAPAN
7.7 ITALY
7.8 MALAYSIA
8 REGIONAL SUMMARY
9 MARKET OVERVIEW
9.1 DRIVERS
9.1.1 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CYSTIC FIBROSIS AND SICKLE CELL ANEMIA
9.1.2 RISE IN INVESTMENT IN R&D FOR DEVELOPMENT OF CELL AND GENE THERAPIES
9.1.3 GOVERNMENT INITIATIVES FOR INITIATION OF CELL AND GENE THERAPY FIELD
9.1.4 INCREASED IMPLEMENTATION OF ADENO-ASSOCIATED VIRUS
9.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE THAWING SYSTEMS
9.2 RESTRAINTS
9.2.1 RISE IN COST ASSOCIATED WITH CELL AND GENE THERAPY ENGINEERING
9.2.2 RISE OF UNWANTED MUTAGENS
9.2.3 TECHNICAL HINDRANCE FACED IN USING THAWING INSTRUMENTS
9.2.4 STRICT REGULATORY FRAMEWORK
9.3 OPPORTUNITIES
9.3.1 INCREASING PREVALENCE OF CANCER
9.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
9.3.3 RISE IN EXPENDITURE IN HEALTHCARE SECTOR
9.4 CHALLENGES
9.4.1 LONG APPROVAL TIME FOR IMMUNOTHERAPIES
9.4.2 LACK OF ACCESSIBILITY
10 IMPACT OF COVID-19 ON EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
10.1 IMPACT ON PRICE
10.2 IMPACT ON DEMAND
10.3 IMPACT ON SUPPLY CHAIN
10.4 STRATEGIC DECISION FOR MANUFACTURERS
10.5 CONCLUSION
11 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY
11.1 OVERVIEW
11.2 BENCH TOP
11.3 PORTABLE
12 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE
12.1 OVERVIEW
12.2 CELL THERAPIES
12.2.1 CAR T CELLS
12.2.2 NK CELLS
12.2.3 MSCS
12.2.4 TILS
12.2.5 OTHERS
12.3 GENE THERAPIES
12.3.1 ADENOVIRUS
12.3.2 ADENO-ASSOCIATED VIRUSES
12.3.3 LENTIVIRUSES
12.3.4 ONCOLYTIC VIRUSES
12.3.5 OTHERS
13 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE
13.1 OVERVIEW
13.2 AUTOMATIC THAWING SYSTEM
13.3 MANUAL THAWING SYSTEM
14 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 UPSTREAM PROCESSING
14.2.1 AUTOMATIC THAWING SYSTEM
14.2.2 MANUAL THAWING SYSTEM
14.3 DOWNSTREAM PROCESSING
14.3.1 AUTOMATIC THAWING SYSTEM
14.3.2 MANUAL THAWING SYSTEM
15 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER
15.1 OVERVIEW
15.2 HOSPITALS AND DIAGNOSTIC LABORATORIES
15.3 BLOOD BANKS AND TRANSFUSION CENTERS
15.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
15.5 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY
15.6 CORD BLOOD AND STEM CELL BANKS
15.7 GENE BANKS
15.8 OTHERS
16 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 THIRD PARTY DISTRIBUTORS
16.4 OTHERS
17 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION
17.1 EUROPE
17.1.1 GERMANY
17.1.2 FRANCE
17.1.3 U.K.
17.1.4 ITALY
17.1.5 SPAIN
17.1.6 RUSSIA
17.1.7 TURKEY
17.1.8 BELGIUM
17.1.9 NETHERLANDS
17.1.10 SWITZERLAND
17.1.11 LUXEMBOURG
17.1.12 REST OF EUROPE
18 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: EUROPE
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 MERCK KGAA
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 PRODUCT PORTFOLIO
20.1.4 RECENT DEVELOPMENTS
20.2 EPPENDORF AG
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 PRODUCT PORTFOLIO
20.2.4 RECENT DEVELOPMENTS
20.3 SARTORIUS AG
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 .RECENT DEVELOPMENTS
20.5 BARKEY
20.5.1 COMPANY SNAPSHOT
20.5.2 PRODUCT PORTFOLIO
20.5.3 RECENT DEVELOPMENTS
20.6 BOEKEL SCIENTIFIC
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 BIOLINE INDIA
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENTS
20.8 COOK
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENT
20.9 GENESIS BPS
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.1 HELMER SCIENTIFIC INC.
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENTS
20.11 LABCOLD
20.11.1 COMPANY SNAPSHOT
20.11.2 PRODUCT PORTFOLIO
20.11.3 RECENT DEVELOPMENTS
20.12 PLEURISTEM THERAPEUTICS INC.
20.12.1 COMPANY SNAPSHOT
20.12.2 REVENUE ANALYSIS
20.12.3 PRODUCT PORTFOLIO
20.12.4 RECENT DEVELOPMENTS
20.13 SARSTEDT AG & CO. KG
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENTS
21 QUESTIONNAIRE
22 RELATED REPORTS
List of Table
TABLE 1 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
TABLE 2 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 3 EUROPE BENCH TOP IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 EUROPE PORTABLE IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 6 EUROPE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 EUROPE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 8 EUROPE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 EUROPE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 10 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 EUROPE AUTOMATIC THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 EUROPE MANUAL THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 EUROPE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 EUROPE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 EUROPE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 EUROPE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 18 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 19 EUROPE HOSPITALS AND DIAGNOSTIC LABORATORIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 EUROPE BLOOD BANKS AND TRANSFUSION CENTERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 EUROPE RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 EUROPE BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 EUROPE CORD BLOOD AND STEM CELL BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 EUROPE GENE BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 EUROPE OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 27 EUROPE DIRECT TENDER IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 EUROPE THIRD PARTY DISTRIBUTORS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 EUROPE OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 31 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 32 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 33 EUROPE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 34 EUROPE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 35 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 36 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 37 EUROPE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 EUROPE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 39 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 40 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 42 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 43 GERMANY CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 44 GERMANY GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 45 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 47 GERMANY UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 GERMANY DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 49 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 50 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 52 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 53 FRANCE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 54 FRANCE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 55 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 FRANCE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 FRANCE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 62 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 63 U.K. CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 64 U.K. GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 65 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 66 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 U.K. UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 U.K. DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 70 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 72 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 73 ITALY CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 74 ITALY GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 75 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 76 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 ITALY UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 78 ITALY DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 80 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 81 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 82 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 83 SPAIN CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 84 SPAIN GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 85 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 86 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 87 SPAIN UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 SPAIN DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 90 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 91 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 92 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 93 RUSSIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 94 RUSSIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 95 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 96 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 97 RUSSIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 98 RUSSIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 99 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 100 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 101 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 102 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 103 TURKEY CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 104 TURKEY GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 105 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 106 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 107 TURKEY UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 108 TURKEY DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 109 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 110 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 111 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 112 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 113 BELGIUM CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 114 BELGIUM GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 115 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 116 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 117 BELGIUM UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 118 BELGIUM DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 120 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 121 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 122 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 123 NETHERLAND CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 124 NETHERLAND GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 125 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 126 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 127 NETHERLAND UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 NETHERLAND DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 129 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 130 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 131 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 132 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 133 SWITZERLAND CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 134 SWITZERLAND GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 135 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 136 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 137 SWITZERLAND UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 138 SWITZERLAND DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 139 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 140 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 141 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 142 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 143 LUXEMBOURG CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 144 LUXEMBOURG GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 145 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 146 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 147 LUXEMBOURG UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 148 LUXEMBOURG DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 149 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 150 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 151 REST OF EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CARDIAC AILMENTS, CYSTIC FIBROSIS AND AIDS IS EXPECTED TO DRIVE THE EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN 2021 & 2028
FIGURE 15 PESTEL ANALYSIS
FIGURE 16 PORTERS FIVE FORCES MODEL
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
FIGURE 18 INCIDENCE OF CYSTIC FIBROSIS OBSERVED IN THE COUNTRIES
FIGURE 19 PREVALENCE OF SICKLE CELL ANEMIA IN AFRICA AND EUROPE
FIGURE 20 NEW CANCER CASES WORLDWIDE, (2018) (IN MILLION)
FIGURE 21 EUROPE CANCER INCIDENCE (2018)
FIGURE 22 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2020
FIGURE 23 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2021-2028 (USD MILLION)
FIGURE 24 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, CAGR (2021-2028)
FIGURE 25 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 26 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2020
FIGURE 27 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2021-2028 (USD MILLION)
FIGURE 28 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, CAGR (2021-2028)
FIGURE 29 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY SAMPLE, LIFELINE CURVE
FIGURE 30 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2020
FIGURE 31 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2021-2028 (USD MILLION)
FIGURE 32 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, CAGR (2021-2028)
FIGURE 33 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 34 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2020
FIGURE 35 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 36 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 37 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 38 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2020
FIGURE 39 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 40 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 41 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 43 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 44 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 45 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 46 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SNAPSHOT (2020)
FIGURE 47 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020)
FIGURE 48 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 49 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 50 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY (2021-2028)
FIGURE 51 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENTMARKET: COMPANY SHARE 2020 (%)
FIGURE 52 COMPANY SHARE ANALYSIS
FIGURE 53 COMPANY SHARE ANALYSIS
FIGURE 54 COMPANY SHARE ANALYSIS
FIGURE 55 COMPANY SHARE ANALYSIS
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
